A 17-Year Observational Analysis of Hospitalized Pediatric Patients with Influenza Virus During the 2009 H1N1 and COVID-19 Pandemics - Report - MDSpire

A 17-Year Observational Analysis of Hospitalized Pediatric Patients with Influenza Virus During the 2009 H1N1 and COVID-19 Pandemics

  • By

  • Hedda Trømborg Jalving

  • Andreas Christensen

  • Svein Arne Nordbø

  • Kari Risnes

  • Henrik Døllner

  • Inger Heimdal

  • February 12, 2026

  • 0 min

Share

Clinical Report: A 17-Year Observational Analysis of Hospitalized Pediatric Patients

Overview

This study evaluates the impact of the 2009 H1N1 and COVID-19 pandemics on pediatric influenza hospitalizations over a 17-year period. It highlights changes in hospitalization rates, age distributions, and disease severity in children with influenza virus infections.

Background

Influenza virus is a significant cause of morbidity and mortality in children, often leading to severe respiratory complications. The 2009 H1N1 pandemic and the COVID-19 pandemic have altered the epidemiology of influenza, with implications for pediatric health. Understanding these changes is crucial for improving clinical management and preventive strategies in pediatric populations.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Hospitalized children during the 2009 H1N1 pandemic showed similar disease severity to those with seasonal influenza.
  • COVID-19 pandemic measures led to a significant decline in influenza cases in 2020 and 2021.
  • After lifting non-pharmacological interventions, there was a surge in influenza cases among children in 2021-2022.
  • Children hospitalized with influenza post-COVID-19 exhibited a higher age distribution and increased disease severity.
  • Clinical complications in hospitalized children were categorized into mild and severe, impacting treatment approaches.

Clinical Implications

Healthcare providers should be aware of the changing epidemiology of influenza in children, particularly following the COVID-19 pandemic. Prompt recognition and treatment of influenza in pediatric patients are essential to mitigate severe outcomes, especially in those with underlying health conditions.

Conclusion

This analysis underscores the need for ongoing surveillance and adaptation of clinical practices in response to evolving influenza epidemiology in pediatric populations. Enhanced understanding of these trends can inform better healthcare strategies.

References

  1. The Journal of Infectious Diseases, 2024 -- Hospitalizations for Pediatric Acute Respiratory Viruses: A Cohort Analysis from 2017 to 2024
  2. Infection, 2024 -- Impact of Respiratory Syncytial Virus Infections in Pediatric Patients During the COVID-19 Pandemic: A Comprehensive Analysis of 11,915 Cases Across Germany
  3. Open Forum Infectious Diseases, 2024 -- Immune Responses to Influenza Infection in Children
  4. Open Forum Infectious Diseases, 2024 -- Geographic Inequities in Hospitalizations for Influenza and Related Illnesses During Seasonal and Pandemic Outbreaks
  5. Influenza Antiviral Medications: Summary for Clinicians | Influenza (Flu) | CDC, 2024
  6. Influenza-Associated Hospitalizations During a High Severity Season | MMWR, 2024
  7. Influenza Antiviral Medications: Summary for Clinicians | Influenza (Flu) | CDC
  8. Influenza-Associated Hospitalizations During a High Severity Season — Influenza Hospitalization Surveillance Network, United States, 2024–25 Influenza Season | MMWR

Original Source(s)

Related Content